Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.00
+0.01 (0.30%)
At close: Sep 11, 2026, 4:00 PM EDT
4.900
-0.100 (-2.00%)
After-hours: Sep 11, 2026, 6:19 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $16.09 million as of September 11, 2026. Its market cap has decreased by -28.31% in one year.
Market Cap
16.09M
Enterprise Value
-8.07M
1-Year Change
-28.31%
Ranking
Category
Stock Price
$5.00
ChartMarket Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $16.09M, a decrease of -98.32%. That is a compound annual growth rate of -46.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 16.09M | -57.11% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cerenome | 17.65M |
| Dyadic International | 17.64M |
| Niki BioSolutions | 16.78M |
| Enlivex | 16.78M |
| PDS Biotechnology | 16.51M |
| BioCardia | 16.35M |
| AEON Biopharma | 16.31M |
| Citius Pharmaceuticals | 15.95M |